DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02165111 (ClinicalTrials.gov)	January 2015	11/6/2014	Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome	A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial Assessing the Therapeutic Efficacy of Botulinum Toxin In Treating Scleroderma-Associated Raynaud's Syndrome	Scleroderma;Raynaud's Syndrome	Drug: Onabotulinumtoxin A;Drug: sterile saline solution	Johns Hopkins University	Allergan	Completed	18 Years	N/A	All	40	Phase 3	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02165111
(ClinicalTrials.gov)

January 2015

11/6/2014

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial Assessing the Therapeutic Efficacy of Botulinum Toxin In Treating Scleroderma-Associated Raynaud's Syndrome

Scleroderma;Raynaud's Syndrome

Drug: Onabotulinumtoxin A;Drug: sterile saline solution

Johns Hopkins University

Allergan

Completed

18 Years

N/A

All

Phase 3

United States